Advertisement
Advertisement
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
20.47
USDSponsored
-0.34
-1.64%
Jan 30, 15:58 UTC -5
Closed
Pre-Market
17.57
-2.90
-14.17%
PHAR Earnings Reports
Positive Surprise Ratio
PHAR beat 20 of 39 last estimates.
51%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$95.79M
/$0.03
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q1 25 (Revenue/ EPS)
+21.11%
/-250.00%
Pharming Group N.V. ADS, each representing 10 ordinary shares earnings per share and revenue
On Jan 08, 2026, PHAR reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of 0.00 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 104.74 million, with a --% difference. The market reacted with a +4.58% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 95.79 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
What were Pharming Group N.V. ADS, each representing 10 ordinary shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Pharming Group N.V. ADS, each representing 10 ordinary shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Pharming Group N.V. ADS, each representing 10 ordinary shares's Q4 2025 earnings?
The stock price moved up 4.58%, changed from $17.89 before the earnings release to $18.71 the day after.
When is Pharming Group N.V. ADS, each representing 10 ordinary shares expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Pharming Group N.V. ADS, each representing 10 ordinary shares's next earnings report?
Based on 4
analysts, Pharming Group N.V. ADS, each representing 10 ordinary shares is expected to report EPS of $0.03 and revenue of $95.79M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement